Retinal transcriptome profile in mice following dexamethasone treatment for endotoxin-induced uveitis

Transcription

1 J South Med Univ, 8, 38(8): 9-99 doi.3969/j.issn Original Article Retinal transcriptome profile in mice following dexamethasone treatment for endotoxin-induced uveitis YU Peng, QIU Yiguo, LIN Ru, FU Xinyu, HAO Bingtao, LEI Bo, 3 Department of Ophthalmology, First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Ophthalmology, Chongqing Eye Institute, Chongqing 46, China; Institute of Cancer Research, Southern Medical University, Guangzhou 555, China; 3 Henan Provincial People's Hospital, Henan Eye Institute, Henan Eye Hospital, Zhengzhou 453, China Abstract: Objective To investigate the changes in retinal transcriptome profile of mice with endotoxin-induced uveitis (EIU) following dexamethasone (DEX) treatment and explore the mechanisms underlying the therapeutic effect of DEX. Methods EIU was induced in BALB/c mice by intravitreal injection of 5 ng lipopolysaccharide (LPS), followed by topical application of DEX (.%) eye drops every 4 h for 4 h. The anterior chamber inflammation was examined with a slit lamp and the clinical scores were assessed. The morphological changes in the eyes were assessed at 4 h after LPS injection. The retinas were harvested for analysis of transcriptome profile using the next-generation sequencing (NGS)-based RNA sequencing (RNA-seq), and the expressions of the inflammatory cytokines and the differentially expressed genes (DEGs) were verified using real-time PCR. Results DEX alleviated the inflammatory response and reduced the mrna expressions of IL-6, TNF-α, MCP- and ICAM- at 4 h after LPS injection. A total of 5 DEGs were identified by RNA-seq. Within these DEGs, 37 genes were upregulated and 5 genes were down-regulated in LPS group as compared with DEX+LPS group. No significantly enriched Gene Ontology (GO) terms was noted. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis showed 6 up-regulated and down-regulated KEGG pathways. RIG-I-like receptor signaling pathway and several immune- and inflammation-related genes including Ifit, H-T4, Mx and Eifak were significantly down regulated by DEX. Verification with RT-PCR yielded results consistent with these findings. Conclusion DEX alleviates LPS-induced inflammatory response in the retina of mice, and such protective effect is probably mediated by RIG-I like receptor signal pathway and the immune-and inflammation-related genes. Keywords: endotoxin-induced uveitis; dexamethasone; transcriptome; RIG-I-like receptor signaling pathway; inflammation INTRODUCTION Uveitis represents a spectrum of common intraocular inflammatory diseases induced by infections or noninfectious factors [], and is a major cause of visual impairment worldwide [, 3]. Among all the cases of uveitis, infectious uveitis accounts for 3%-5% in developing countries [4]. The pathogens of infectious uveitis includes bacteria, fungi, viruses, and parasites, and the treatment remains clinically challenging [5]. As a well-studied model for acute infectious uveitis in human, endotoxininduced uveitis (EIU) is induced by intravenous or intravitreal injection with lipopolysaccharide (LPS) [6, 7] to produce such prominent features as iris hyperemia, leukocyte infiltration and protein leakage, normally reaching their peak levels at 4 h after LPS injection [7, 8]. Received: 8--3 Accepted: 8-5- Supported by National Natural Science Foundation of China (8476, ), Science and Technology Bureau of Henan Province (8345), and National Key Clinical Specialties Construction Program of China. YU Peng and QIU Yiguo contributed equally to this work as cofirst authors. Corresponding author: LEI Bo, MD, PhD, bolei99@6.com LPS stimulation can evoke the production of numerous inflammatory cytokines including interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein- (MCP-) and intercellular adhesion molecule- (ICAM-), and blocking the activity of these cytokines reduces intraocular inflammatory response [8- ], indicating the essential role of inflammatory cytokines in the pathologies of LPS-induced uveitis. Corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs) and immunosuppressive agents have been used to treat uveitis for several decades [3, 4]. Corticosteroids currently remain the primary choice for initial treatment of uveitis. Dexamethasone (DEX) is used for treatment of a wide variety of diseases including anaphylactic diseases, immune diseases and inflammatory diseases, and is also a conventional drug prescribed for various inflammatory ocular diseases due to its strong anti-inflammatory effects [5]. Nevertheless, long-term use of DEX has been shown to lead to a series of systemic and topical side effects [5, 6]. So far studies of DEX focus primarily on specific pathways and cytokines, and an overall picture of the mechanisms for its beneficial or adverse effects is not available; integrating these molecular

2 9 J South Med Univ, 8, 38(8): mechanisms into a general map provides better insights into the beneficial and side effects of DEX in uveitis treatment. RNA sequencing (RNA-seq) is a novel approach for both mapping and quantifying transcriptomes based on high-throughput sequencing technology [7]. The quantitative RNA-seq platforms provide unbiased profiles, a snapshot of the transcriptome of cells, and the ability to identify unknown transcribed regions, and can be extremely precise if a sufficient level of coverage is obtained [8, 9]. Hence, RNA-seq can be instrumental for revealing comprehensive yet specific changes in the transcriptome. Gene expression profiling using nextgeneration sequencing (NGS)-based RNA-seq technology allows for more thorough understanding of the molecular events caused by DEX. In the present study, we aimed to obtain the transcriptome profile of the retinas from DEX-treated mice with EIU using NGS- based RNA-seq technology. Our findings may add to the current knowledge base and shed light on the mechanisms of the protective roles of DEX against ocular inflammation. MATERIALS AND METHODS Ethics statement All the experimental procedures were carried out in accordance with the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research. The protocols were approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University. In all the procedures the mice were appropriately anesthetized and efforts were made to relieve the discomforts and stress []. Animal grouping and treatments Female BALB/c mice were purchased from Jackson Laboratories (Bar Harbor, ME) and housed in the Animal Care Service of Chongqing Medical University with a h: h light/dark cycle. The mice at the age of 6 to 8 weeks were randomly assigned into 3 groups: normal control group without any treatment, LPS group with intravitreal injection of 5 ng/μl LPS (Sigma- Aldrich, St. Louis, MO, USA) in one eye to induce EIU, and DEX + LPS group with LPS injection followed by treatment with topical application of.% DEX eyedrops every 4 h for 4 h. Clinical Assessment of EIU The inflammatory signs in the anterior chamber were assessed using a digital slit-lamp microscope at 4 h after LPS injection. To ensure the accuracy of assessment, the clinical severity of ocular inflammation was classified by two independent observers in line with the clinical scoring criteria as previously described []. Histopathology For histopathological assessment, the eyeballs of the mice were enucleated at 4 h after LPS injection and fixed in a mixture consisting of acetone (5 ml), glacial acetic acid ( ml), formaldehyde (4 ml), and distilled water (3 ml) at 4 for 4 h. After embedment in paraffin, the samples were serially sliced (4 to 6 μm) through the pupillary-optic nerve axis and stained with hematoxylin and eosin (HE). Histopathologic evaluation of the eyeballs was carried out by assessing the number of infiltrating cells in the posterior and anterior chambers under an optical microscope. Real-time PCR analysis The total RNA of neural retina was extracted with Trizol Reagent (Invitrogen, Carlsbad, CA, USA) following the manufacturer's instructions. For quantitative PCR, cdna was synthesized using the PrimeScript RT reagent kit (Takara Biotechnology, Dalian, China). PCR amplification was performed using a real-time PCR system (ABI 75 system, Applied Biosystems, Foster City, CA, USA) with SYBR Green (Vazyme Biotech Co., Ltd, Nanjing, China). The thermal cycles were carried out with initial denaturation at 95 for min, followed by 4 cycles of 95 for 5 s and 6 for mi. To determine the mrna levels, GAPDH was used as the endogenous reference gene. All the samples were prepared in duplicate and the average Ct values were used for quantification. Relative quantification was achieved using the comparative -ΔΔCt method. The control group was used as the calibrator to calculate the relative fold change of the mrna of the target gene X in the experimental group (EG): ΔΔCt=(Ct.X EG-Ct.GAPDH EG)/ (Ct.X control-ct.gapdh control) []. The sequences of primers and GenBank accession numbers of the target genes are listed in Tab.. Library construction and mrna-seq RNA-seq and data analysis were conducted by Novogene (Beijing, China). Total RNA of mouse retinas were extracted using TRIzol reagent (Invitrogen) and purified with RNase-free DNase I (New England Biolabs, MA, USA) following the manufacturer's protocol. Containing 3 μg RNA for each sample, the sequencing libraries were constructed using NEB Next Ultra RNA Library Prep Kit for Illumina (New England Biolabs, MA, USA). The mrna was isolated from the total RNA using Dynabeads oligo (dt) (Invitrogen Dynal) and the double-strand cdnas were synthesized using Superscript II reverse transcriptase (Invitrogen). The cdnas were then fragmented by nebulization and the RNA sequencing library was established according to standard Illumina protocol. The library quality was verified using Agilent Bioanalyzer (Agilent Technologies, Palo Alto, CA) followed by sequencing with the Illumina Hiseq 5, and bp/5 bp singleend reads were generated. The single-end clean reads were aligned to the genome by the split read aligner TopHat (v..) with the mismatches set at under default parameter settings []. Analysis of differentially expressed genes (DEGs)

3 J South Med Univ, 8, 38(8): Tab. Sequences of the primers for amplifying the genes using real-time RT-PCR Gene Forward Reverse Accession number IL-6 5'-ACCACGGCCTTCCCTACTTC-3' 5'-AGATTGTTTTCTGCAAGTGCATCA-3' NM_3454. TNF-a 5'-GCCTCTTCTCATTCCTGCTT-3' 5'-CTCCTCCACTTGGTGGTTTG-3' NM_ MCP- 5'-CCCCACTCACCTGCTGCTACT-3' 5'-GGCATCACAGTCCGAGTCACA-3' NM_333 ICAM- 5'-AGATCACATTCACGGTGCTG-3' 5'-CTGGCCTCGGAGACATTAGA-3' NM_493. Ddx58 5'-GAGTTCCTGGCTCGAGGATG-3' 5'-TGACTGCAGCTTCAACAGGT-3' NM_ Ifih 5'-GATGTTCTGCGCCAAACTGG-3' 5'-ACTTGTGTCTGATTCTGTGTTGTC-3' NM_ Isg5 5'-TGGTACAGAACTGCAGCGAG-3' 5'-AGCCAGAACTGGTCTTCGTG-3' NM_ Mx 5'-CAGAGAGACTGACCGCAGAG-3' 5'-GGGCAGTGATGTCCTGGTTA-3' NM_366. Ifit 5'-TTCCGTAGGAAACATCGCGT-3' 5'-CATGAATGGCCTGTTGTGCC-3' NM_833.3 The DEGs were analyzed using the DESeq R package (version..), which has been a routine statistical approach to determine the digital differential expressions of genes using a model assuming negative binomial distribution of the data. To control the false positive rate, the Benjamini and Hochberg's approach was used for adjusting the P values, and a P value less than.5 was considered to indicate a significant difference. Functional enrichment analysis Gene Ontology (GO) enrichment analysis was performed to functionally annotate the DEGs using the GOseq R package. The GO ontologies include 3 key biological domains including the biological process, cellular component and molecular function []. An adjusted P value <.5 was considered to indicate a significantly enriched GO term. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis was carried out to annotate the pathway enrichment. The KEGG pathway enrichment of the DEGs was conducted using KOBAS software, and a significantly enriched KEGG pathway was defined for an adjusted P value <.5. Statistical analysis All the data of the continuous variables are presented as Mean±SE. The clinical scores and data of real-time PCR analysis were analyzed with the GraphPad Prism 5 software. The clinical scores were analyzed using Kruskal-Wallis test and the data of the inflammatory cytokines were analyzed using one-way ANOVA followed by Bonferroni correction. The validation data were analyzed using unpaired t-test. A P value less than.5 was considered to indicate a significant difference. RESULTS DEX alleviates inflammation in mice with EIU Compared with the normal control group, the mice with intravitreal injection of LPS exhibited obvious iris hyperemia, exudation into the anterior chamber, and hypopyon. Treatment with DEX markedly ameliorated these inflammatory signs (Fig.A). Assessment of the clinical scores indicated that DEX significantly reduced the severity of ocular inflammation induced by LPS group (Fig.B). DEX reduces infiltrating inflammatory cells in mice with EIU Compared with the normal control group, intravitreal injection of LPS resulted in obvious inflammation in the A Untreated DEX+LPS LPS B Clinical score Front view Clinical score ** Lateral view Fig. Inflammation in the anterior chamber of the mice in different groups. A: Representative images showing inflammations in the anterior chamber of the mice in the untreated (normal control), LPS and DEX+LPS groups; B: Clinical scores assessed at 4 h by two independent observers (n=, Mean±SE). **P<., P<. by Kruskal-Wallis test.

4 94 J South Med Univ, 8, 38(8): vitreous cavity and the ciliary body, where numerous infiltrating inflammatory cells were observed 4 h after LPS injection. DEX treatment significantly reduced the number of infiltrating cells compared with the LPS group (Fig.). Untreated DEX+LPS LPS Fig. Infiltrating cells in the posterior and anterior chambers of the mice with EIU and DEX treatment at 4 h after LPS injection (HE staining, ). DEX reduces LPS-induced inflammatory cytokine expressions The inflammatory cytokines IL-6, TNF-α, MCP- and ICAM- play a vital role in the development of inflammation in mouse models of EIU [9,, 3, 4]. Compared with the normal control group, LPS injection induced significantly increased expressions of these cytokines, and topical application of DEX lowered the level of IL-6 by approximately.8 folds, TNF-α by 3. folds, MCP- by. folds and ICAM- by.9 folds (Fig.3). Retinal DEG profiling in mice with EIU and DEX treatment The volcano plot showed 5 DEGs (adjusted P<.5) in the retinas of mice following intravitreal injection of LPS with and without DEX treatment. Among these DEGs, 37 (7% ) genes were up- regulated and 5 (9% ) were down-regulated in the mice with EIU as compared with the mice with DEX treatment (Fig.4). The heatmap and hierarchical clusters analyses (Fig.5) highlighted distinct differences in the expression levels of the 5 DEGs between the two groups. GO enrichment analysis of the DEGs GO functional enrichment analysis was performed for the DEGs identified by RNA-seq, and the top 3 enriched up-regulated and down-regulated GO terms are shown in Fig.6. No significantly enriched GO terms were found in either the up-regulated or the down-regulated terms. KEGG pathway analysis of DEGs The top up-regulated and down-regulated KEGG pathways with enrichment are shown in Fig.7. Six upregulated pathways were found to be significantly enriched in mice with EIU as compared with the DEXtreated mice, involving herpes simplex infection, influenza A, measles, RIG-I-like receptor signaling pathway, hepatitis C and ribosome; down-regulated pathways were significantly enriched in the mice with EIU, involving ribosome, vitamin digestion and absorption. The significantly enriched KEGG pathways are listed in Tab.. Validation of DEGs with real-time PCR Eight genes (adjusted P<.5) involved in the significantly up-regulated KEGG pathways were selected for validation using real-time PCR (Tab.3). These genes are associated with pathogen infection and innate immune response, and are divided into 3 categories: RIG-I-like receptor signaling pathway related genes (Ddx58, Ifih, and Isg5); immune and inflammation regulation related genes (Mx, Ifit, H-T4, and Eifak); and inflammatory response related genes (Ccl). The results of RNA-seq demonstrated significant up-regulation of these selected genes in mice with EIU as compared with DEX-treat mice, suggesting that DEX can significantly down-regulate these genes. The results of real-time PCR validation were consistent with the results of RNA- seq (Fig.8). DISCUSSION DEX is commonly used for treatment of many inflammatory and autoimmune ocular diseases [5]. Our

5 J South Med Univ, 8, 38(8): IL-6 3 * * TNF-α * ** MCP- ICAM * * Fig.3 DEX decreases the over- production of inflammatory cytokines evoked by LPS. The mrna levels of the cytokines IL-6, TNF-α, MCP- and ICAM- were detected using realtime PCR. The data are presented as Mean ± SE (n=6-8) and analyzed with one- way ANOVA followed by Bonferroni correction. P<., **P<., *P<.5. -log (padj) LPS vs D+LPS - log (fold change) Differential expressed genes (5) up: 37 down: 5 Fig.4 Volcano plot showing 5 DEGs (adjusted P<.5) in the retina of mice with LPS versus DEX+LPS treatment. results demonstrate that DEX can significantly ameliorate the inflammation in the anterior chamber and reduce the over-expression of the inflammatory cytokines IL-6, TNF-α, MCP- and ICAM- induced by LPS stimulation. The results of transcriptome analysis reveal that the protective effect of DEX is probably associated with RIG-I-like receptors (RLRs) signaling pathway and several immune- and inflammation-related genes, including Mx, Ifit, H-T4 and Eifak. To our knowledge, this is the first report of the specific pathway and genes that potentially mediate the therapeutic effect of DEX on uveitis; identification of this pathway and the involved genes may enrich the understanding of the mechanisms of uveitis and benefits the development of novel therapeutic strategies. The pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs), RLRs, and NOD-like receptors (NLRs), recognize the invasive pathogens and subsequently trigger an antimicrobial immune response and the production of pro-inflammatory cytokines and chemokines [6-8]. The RLRs, including retinoic acidinducible gene I (RIG-I, also known as DDX58) [9] and melanoma differentiation-associated gene 5 (MDA5, also known as IFIH) [3], are a family of cytosolic RNA helicases that can specifically recognize viral RNA and initiate innate immunity. The RLRs signal pathway can increase the production of type I interferon and activate the antiviral genes to trigger intracellular immunity and inflammation to control virus infection [3, 3]. Anomalies in RLRs signaling is associated with several autoimmune and inflammatory diseases. Therefore, normal regulation of the RLRs signaling pathway is crucial to avoid tissue injury induced by superfluous immune response [3]. Recent studies showed that RLRs also participate in the recognition of intracellular bacteria [33, 34]. There is evidence that RLRs are capable of detecting the RNA of intracellular Salmonella enterica serovar Typhimurium and subsequently activate type I interferon to evoke the innate immunity [35]. Bacterial LPS stimulation of the endothelial cells increases the expression of RIG-I, and then selectively up-regulates the expression of inflammatory enzyme cyclooxygenase (COX-), suggesting that RIG-I plays a key role in pro-inflammatory pathways [36]. Furthermore, transmissible gastroenteritis virus (TGEV) infection is found to significantly up-regulate the RLRs

6 96 J South Med Univ, 8, 38(8): LPS LPS LPS3 D+LPS D+LPS D+LPS3 Fig.5 Heatmap and hierarchical clusters analysis of the DEGs in the retina between mice in LPS and DEX+LPS groups (n=3). Each small box indicates the expression status of a certain gene in one sample, red for up-regulated and blue for down-regulated expression. Up-regulated GO terms Down-regulated GO terms GO term GO term Type Biological process Cellular component Molecular function Number of genes Number of genes Fig.6 GO enrichment analysis of the LPS versus DEX + LPS group. GO functional analysis shows the top 3 enriched up- and down-regulated GO Terms. No GO term was significantly enriched (adjusted P>.5). (RIG-I and MDA5), whereas RLRs knockdown decreases the pro-inflammatory cytokines and the phosphorylation of NF-κB subunit p65 [37]. Consistent with the previous findings, our transcriptome analysis show that DEX markedly down-regulate the RLRs in mice with EIU, suggesting that the protective effect of DEX is related to the down-regulation of RLRs, and inhibiting RIG-I may be a promising strategy for treatment of ocular inflammation. The immune- and inflammation-related genes from the enriched KEGG pathway, including Ifit, Mx, H- T4 and Eifak, play a vital role in antiviral immune response and also in multiple immune and inflammatory diseases. A recent study found that Ifit gene was overexpressed in the peripheral blood of patients with systemic lupus erythematosus (SLE) [38], and possibly by interacting with Rho/Rac GEF [38] and subsequently

7 J South Med Univ, 8, 38(8): Up-regulated KEGG pathway Down-regulated KEGG pathway Rich factor..3.4 Rich factor Fig.7 KEGG enrichment analysis between LPS and DEX+LPS groups. KEGG functional analysis showed the top enriched up- and down-regulated KEGG pathways, including 6 significantly up-regulated and significantly down-regulated KEGG pathways (adjusted P<.5) Ddx58 **.5..5 LPS Ifih Isg5 Mx *.5 **.5 ** DEX+LPS Ifit.5..5 H-T4 *.5..5 Eifak.5..5 Ccl Fig.8 Validation of the DEGs by real-time PCR. Eight genes from the markedly enriched KEGG pathways were selected (adjusted P<.5). The mrna expressions of RIG-I-like receptor signaling pathway related genes Ddx58, Ifih, and Isg5, immune- and inflammation-related genes Mx, Ifit, H-T4, and Eifak, and inflammatory response-related gene Ccl were significantly decreased in the DEX +LPS group compared with LPS group. All data are shown as Mean±SE. P<., **P<., *P<.5 by unpaired t-test (n=6-8). activating JNK and p38mapk, participated in the immune responses in SLE [39]. The over-expression of EIFAK increases the activity of NLRP3 inflammasome, whereas silencing or suppression of EIFAK expression lowers the activity of NLRP3 inflammasome to inhibit the secretion of IL-β, IL-8 and high-mobility group box (HMGB) [4]. These evidences suggest the pro-inflammatory role of Ifit and Eifak in inflammatory diseases. Nevertheless, the role of Mx and H-T4 in immune and inflammation regulation remains unclear. Here, we show that LPS stimulation increases the expressions of Ifit, Mx, H-T4 and Eifak, whereas DEX treatment down-regulates their expressions in the retina of mice, suggesting that Mx and H-T4 are also involved in the immune and inflammatory responses in EIU. Taken together, our transcriptome analysis indicate that DEX significantly down-regulates RLRs (DDX58 and IFIH) and the immune- and inflammation-related genes including Ifit, Mx, H-T4 and Eifak,

8 98 J South Med Univ, 8, 38(8): Tab. Significantly enriched KEGG pathways in the retina of mice with EIU Pathway ID Pathway terms P Corrected P mmu568 Herpes simplex infection.. mmu564 Influenza A.. Up-regulated mmu56 mmu46 Measles RIG-I-like receptor signaling pathway mmu56 Hepatitis C.6.3 mmu3 Ribosome.5.3 Down-regulated mmu3 Ribosome.. mmu4977 Vitamin digestion and absorption.3.3 Tab.3 Genes validated by real-time PCR Ensgene Symbol Adjusted P Description ENSMUSG496 Ddx58.8 DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 ENSMUSG6896 Ifih.6 interferon induced with helicase C domain ENSMUSG3569 Isg5. ISG5 ubiquitin-like modifier ENSMUSG334 Mx. MX dynamin-like GTPase ENSMUSG34459 Ifit. interferon-induced protein with tetratricopeptide repeats ENSMUSG53835 H-T4. histocompatibility, T region locus 4 ENSMUSG479 Eifak.3 eukaryotic translation initiation factor -alpha kinase indicating their involvement in mediating the protective effect of DEX. Further investigations for functional verification of RLRs signaling pathway and these genes using RNA interference or pharmacological inhibition are warranted to confirm the mechanism underlying the protective effect of DEX against EIU. REFERENCES: [] Tabbara KF. Infectious uveitis: a review[j]. Arch Soc Esp Oftalmol,, 75 (4): 5-9. [] Miserocchi E, Fogliato G, Modorati G, Bandello F. Review on the worldwide epidemiology of uveitis[j]. Eur J Ophthalmol, 3, 3(5): [3] Munoz-Fernandez S, Martin-Mola E. Uveitis[J]. Best Pract Res Clin Rheumatol, 6, (3): [4] Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis[j]. Indian J Ophthalmol, 7, 55 (3): [5] Majumder PD, Ghosh A, Biswas J. Infectious uveitis: an enigma[j]. Middle East Afr J Ophthalmol, 7, 4(): -. [6] Rosenbaum JT, Mcdevitt HO, Guss RB, et al. Endotoxin-induced uveitis in rats as a model for human disease[j]. Nature, 98, 86 (5773): 6-3. [7] Bhattacherjee P, Williams RN, Eakins KE. An evaluation of ocular inflammation following the injection of bacterial endotoxin into the rat foot pad[j]. Invest Ophthalmol Vis Sci, 983, 4(): 96-. [8] Koizumi K, Poulaki V, Doehmen S, et al. Contribution of TNF-α to leukocyte adhesion, vascular leakage, and apoptotic cell death in endotoxin-induced uveitis in vivo[j]. Invest Ophthalmol Vis Sci, 3, 44(5): [9] Becker MD, Garman K, Whitcup SM, et al. Inhibition of leukocyte sticking and infiltration, but not rolling, by antibodies to ICAM- and LFA- in murine endotoxin-induced uveitis[j]. Invest Ophthalmol Vis Sci,, 4(): []de Vos AF, Klaren VN, Kijlstra A. Expression of multiple cytokines and IL-RA in the uvea and retina during endotoxin-induced uveitis in the rat[j]. Invest Ophthalmol Vis Sci, 994, 35(): []Hoekzema R, Murray PI, van Haren MA, et al. Analysis of interleukin-6 in endotoxin-induced uveitis [J]. Invest Ophthalmol Vis Sci, 99, 3(): []Tuaillon N, Shen DF, Berger RB, et al. MCP- expression in endotoxin-induced uveitis[j]. Invest Ophthalmol Vis Sci,, 43 (5): [3]Lee FF, Foster CS. Pharmacotherapy of uveitis [J]. Expert Opin Pharmacother,, (7): [4]Read RW. Uveitis: advances in understanding of pathogenesis and treatment[j]. Curr Rheumatol Rep, 6, 8(4): 6-6. [5]Sherif Z, Pleyer U. Corticosteroids in ophthalmology: Past-Present - Future[J]. Ophthalmologica,, 6(5): [6]Saraiya NV, Goldstein DA. Dexamethasone for ocular inflammation [J]. Expert Opin Pharmacother,, (7):7-3. [7]Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics[j]. Nat Rev Genet, 9, (): [8]Sultan M, Schulz MH, Richard H, et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome[j]. Science, 8, 3(589): [9]Nagalakshmi U, Wang Z, Waern K, et al. The transcriptional landscape of the yeast genome defined by RNA sequencing [J]. Science, 8, 3(588): []Qiu Y, Yu P, Lin R, et al. Genome-wide retinal transcriptome analysis of endotoxin-induced uveitis in mice with next- generation sequencing[j]. Mol Vis, 7, 3: []Qiu Y, Shil PK, Zhu P, et al. Angiotensin-converting enzyme (ACE) activator diminazene aceturate ameliorates endotoxininduced uveitis in mice[j]. Invest Ophthalmol Vis Sci, 4, 55(6): []Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium[J]. Nat Genet,, 5(): 5-9. [3]Mo JS, Matsukawa A, Ohkawara S, et al. Role and regulation of IL-8 and MCP- in LPS-induced uveitis in rabbits[j]. Exp Eye Res, 999, 68(3):

9 J South Med Univ, 8, 38(8): [4]Shen DF, Chang MA, Matteson DM, et al. Biphasic ocular inflammatory response to endotoxin-induced uveitis in the mouse[j]. Arch Ophthalmol,, 8(4): 5-7. [5]Gordon DM. Use of dexamethasone in eye disease[j]. J Am Med Assoc, 96, 7: 3-. [6]Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[j]. Immunity,, 34 (5): [7]Elinav E, Strowig T, Henao-Mejia J, et al. Regulation of the antimicrobial response by NLR proteins[j]. Immunity,, 34(5): [8]Kato H, Takahasi K, Fujita T. RIG-I-like receptors: cytoplasmic sensors for non-self RNA[J]. Immunol Rev,, 43(): 9-8. [9]Yoneyama M, Kikuchi M, Natsukawa T, et al. The RNA helicase RIG- I has an essential function in double-stranded RNA- induced innate antiviral responses[j]. Nat Immunol, 4, 5(7): [3]Kang DC, Gopalkrishnan RV, Lin L, et al. Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene[j]. Oncogene, 4, 3(9): [3]Peng Y, Xu R, Zheng X. HSCARG negatively regulates the cellular antiviral RIG-I like receptor signaling pathway by inhibiting TRAF3 ubiquitination via recruiting OTUB[J]. PLoS Pathog, 4, (4): e44. [3]Loo YM, Gale MJ. Immune signaling by RIG-I-like receptors[j]. Immunity,, 34(5): [33]Patel JR, Garcia-Sastre A. Activation and regulation of pathogen sensor RIG-I[J]. Cytokine Growth Factor Rev, 4, 5(5): [34]Dixit E, Kagan JC. Intracellular pathogen detection by RIG-I-like receptors[j]. Adv Immunol, 3, 7: [35]Schmolke M, Patel JR, de Castro E, et al. RIG-I detects mrna of intracellular Salmonella enterica serovar Typhimurium during bacterial infection[j]. MBio, 4, 5(): e6-4. [36]Imaizumi T, Aratani S, Nakajima T, et al. Retinoic acid-inducible gene-i is induced in endothelial cells by LPS and regulates expression of COX-[J]. Biochem Biophys Res Commun,, 9 (): [37]Ding Z, An K, Xie L, et al. Transmissible gastroenteritis virus infection induces NF-kappaB activation through RLR-mediated signaling[j]. Virology, 7, 57: 7-8. [38]Ye S, Pang H, Gu YY, et al. Protein interaction for an interferoninducible systemic lupus associated gene, IFIT[J]. Rheumatology (Oxford), 3, 4(): [39]Esteve P, Embade N, Perona R, et al. Rho-regulated signals induce apoptosis in vitro and in vivo by a p53-independent, but Bcl dependent pathway[j]. Oncogene, 998, 7(4): [4]Lu B, Nakamura T, Inouye K, et al. Novel role of PKR in inflammasome activation and HMGB release[j]. Nature,, 488 (743): 余鹏, 邱一果, 林茹, 符馨予, 郝冰涛, 3, 雷博 重庆医科大学附属第一医院眼科 // 眼科学重庆市市级重点实验室 // 重庆市眼科研究所, 重庆 46; 南方医科大学癌症研究所, 广东广州 555; 3 河南省人民医院, 河南省立眼科研究所, 河南郑州 453 摘要 : 目的研究地塞米松 (DEX) 对内毒素诱导性葡萄膜炎 (EIU) 的治疗效果及转录组测序探讨其潜在的机制 方法将 5 ng 脂多糖 ( LPS) 注射入雌性 BALB/c 小鼠玻璃体内建立 EIU 模型, 每隔 4 h 用.% DEX 滴眼, 共 6 次 注射 LPS 后 4 h 用裂隙灯观察小鼠眼前房炎症情况并进行临床评分 苏木精 - 伊红染色法观察小鼠眼部形态学变化 RNA-seq 对 EIU 模型组和 DEX 治疗组小鼠的视网膜进行转录组测序并进行 GO 和 KEGG 功能分析 Real-time PCR 检测小鼠视网膜炎症细胞因子表达及验证选出的差异基因 结果连续滴眼 6 次后,DEX 可减轻 EIU 前房的炎症, 并下调炎症因子白介素 -6(IL-6) 肿瘤坏死因子 -α(tnfα) 单核细胞趋化蛋白 -(MCP-) 和细胞间黏附分子 -(ICAM-)mRNA 的表达 RNA-seq 共检测出 5 个差异基因, 与 DEX+ LPS 组相比,LPS 组中上调的基因有 37 个, 下调的基因有 5 个 差异基因的功能分析未发现显著富集的 GO 条目 KEGG 富集分析显示有 6 个显著上调的 KEGG 通路和 个显著下调的 KEGG 通路 KEGG 结果提示 DEX 治疗后可下调 RIG-I 类受体信号通路 (Ddx58 Ifih 和 Isg5) 及一些免疫炎症相关基因 (Ifit H-T4 Mx 和 Eifak) 结论 DEX 对 LPS 引起的小鼠内毒素诱导性小鼠葡萄膜炎有保护作用, 此保护作用可能与下调 RIG-I 类受体信号通路及一些免疫炎症相关基因有关 关键词 : 转录组测序 ; 内毒素诱导性葡萄膜炎 ;RIG-I 类受体信号通路 ; 炎症 ; 地塞米松 收稿日期 :8--3 基金项目 : 国家自然科学基金 (8476,877949); 河南省科技攻关项目 (8345); 中国国家重点临床专业建设项目作者简介 : 余鹏, 硕士研究生, @qq.com 通信作者 : 雷博, 教授, 博士, 电话 :3-8985, bolei99@6.com